Study reveals potential new strategy for managing inflammatory bowel disease
Celltrion unveils promising dose escalation results for subcutaneous infliximab
Related Posts
Lupin to develop near-zero global warming inhalers
Eco-friendly inhalers aim to reduce environmental impact Lupin Healthcare UK Ltd has announced plans to […]
Digital health collaboration to trial AI-powered X-rays for lung cancer detection
Earlier diagnosis could increase patient survival rates by five years or more […]
Sarah Jones – PharmaTimes
M+F Health has announced the appointment of Sarah Jones as a Director M+F Health has announced […]